New drug JP-1366 put through safety check with heart meds
NCT ID NCT07265466
First seen Dec 10, 2025 · Last updated May 13, 2026 · Updated 21 times
Summary
This early-stage study is testing a new drug called JP-1366 in 96 healthy adults to see if it safely interacts with common heart medications like clopidogrel, aspirin, atorvastatin, and apixaban. The goal is to measure how the body processes these drugs together and check for any side effects. Participants must be healthy, aged 19 to 64, and have a normal body weight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG DRUG INTERACTION (DDI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cha University Bundang Medical Center
RECRUITINGSeongnam-si, Gyeonggi-do, 13496, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.